Home Cart Sign in  
Chemical Structure| 959841-49-7 Chemical Structure| 959841-49-7

Structure of (E)-Akt inhibitor-IV
CAS No.: 959841-49-7

Chemical Structure| 959841-49-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(E)-Akt inhibitor-IV ((E)-AKTIV) is a PI3K-Akt inhibitor with significant cytotoxicity.

Synonyms: (E)-AKTIV

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (E)-Akt inhibitor-IV

CAS No. :959841-49-7
Formula : C31H27IN4S
M.W : 614.54
SMILES Code : CN(C1=CC=CC=C1)/C=C/C2=[N+](C3=CC=CC=C3)C4=CC=C(C5=NC6=CC=CC=C6S5)C=C4N2CC.[I-]
Synonyms :
(E)-AKTIV
MDL No. :N/A

Safety of (E)-Akt inhibitor-IV

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of (E)-Akt inhibitor-IV

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • PI3K

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NCG mice Orthotopic liver cancer model Oral gavage 7.5 µmol/kg Once daily for three weeks Evaluate the inhibitory effects of (E)-Akt inhibitor-IV on liver tumor growth in vivo. Results showed that (E)-Akt inhibitor-IV significantly suppressed tumor growth and lung metastasis, and promoted apoptosis through the induction of endoplasmic reticulum stress. J Transl Med. 2024 Aug 28;22(1):792

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.63mL

0.33mL

0.16mL

8.14mL

1.63mL

0.81mL

16.27mL

3.25mL

1.63mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories